PLUS1
Best deals to access real time data! |
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 41.20 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Roche Holding (QX) | RHHBY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -1.19 | -2.81% | 41.20 | 42.16 | 41.20 | 42.16 | 42.39 | 16:00:42 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 41.20 | 41.25 | 0.05 | 0.12% | - | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,343 | 2,152,251 | $ 41.5005 | $ 89,319,536 | 1,172,987 | 25.10 - 42.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:06:36 | average | 100,000 | $ 41.25 | USD |
Roche Holding (QX) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 35.54B | 862.56M | $ 10.45B | - | - | 862.39M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 6.73M | $ - | 0.00% | - | - |
Roche Holding (QX) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/24/2020 | 07:52 | Dow Jones News | Genentech: Tecentriq Misses Endpoint in Muscle-Invasive.. |
| 1/13/2020 | 13:14 | Dow Jones News | Illumina, Roche Enter Partnership to Use Genomics for.. |
| 1/10/2020 | 18:33 | Dow Jones News | Bristol-Myers Squibb, Macy's, Grubhub: Stocks That Defined.. |
| 12/23/2019 | 07:48 | Dow Jones News | Sarepta Shares Gain After Licensing Deal With Roche |
| 12/23/2019 | 05:59 | Dow Jones News | Drugmakers Turn to Data Mining to Avoid Expensive, Lengthy.. |
| 12/23/2019 | 05:31 | Dow Jones News | Sensyne Health Signs AI Research Pact With Roche |
| 12/23/2019 | 02:25 | Dow Jones News | Roche Enters Licensing Agreement With Sarepta Therapeutics.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RHHBY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.31 | 42.88 | 41.20 | 42.48 | 704,422 | -1.11 | -2.62% |
| 1 Month | 40.62 | 42.88 | 40.36 | 41.05 | 1,199,510 | 0.58 | 1.43% |
| 3 Months | 37.57 | 42.88 | 36.97 | 39.25 | 1,192,250 | 3.63 | 9.66% |
| 6 Months | 33.59 | 42.88 | 25.10 | 37.02 | 1,300,158 | 7.61 | 22.66% |
| 1 Year | 32.27 | 42.88 | 25.10 | 35.50 | 1,226,386 | 8.93 | 27.67% |
| 3 Years | 29.03 | 42.88 | 25.10 | 31.94 | 1,409,203 | 12.17 | 41.92% |
| 5 Years | 35.52 | 42.88 | 0.000507 | 32.18 | 1,324,645 | 5.68 | 15.99% |
Roche Holding (QX) Description
| Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve peoples lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceutical Industry by the Dow Jones Sustainability Indices (DJSI). |
